Crossref
Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions
Biomed Pharma Reviews · 25.01.2026 · 2 (1) · 1-9
DOI: 10.62587/bmpr.2.1.2026.1-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomed Pharma Reviews, online erschienen am 25.01.2026. Verfasst von James Bennett und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bennett, J., & Mitchell, A. (2026). Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions. Biomed Pharma Reviews, 2(1), 1-9. https://doi.org/10.62587/bmpr.2.1.2026.1-9
Vancouver
Bennett J, Mitchell A. Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions. Biomed Pharma Reviews. 2026;2(1):1-9. doi:10.62587/bmpr.2.1.2026.1-9
BibTeX
@article{Bennett2026,
author = {Bennett, James and Mitchell, Andrew},
title = {Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions},
journal = {Biomed Pharma Reviews},
year = {2026},
volume = {2},
number = {1},
pages = {1--9},
doi = {10.62587/bmpr.2.1.2026.1-9}
}
EUVIMED